Preventive strategies to lower the burden of Lyme borreliosis: a cost-utility analysis

Research output: Contribution to conferenceAbstract

Abstract

Lyme borreliosis (LB), a bacterial tick-borne disease caused by Borrelia burgdorferi, has an increasing incidence in the Netherlands. A vaccine for LB is currently not available and mitigation therefore relies on strategies to prevent infections. However, their cost-effectiveness is not known. This project evaluated the public health impact of different LB prevention strategies in the Netherlands using a cost-utility analysis.
Original languageEnglish
Number of pages2
Publication statusPublished - 30 Oct 2020
Event2020 World One Health Congress - Virtual
Duration: 30 Oct 20203 Nov 2020

Conference/symposium

Conference/symposium2020 World One Health Congress
Period30/10/203/11/20

Fingerprint

Dive into the research topics of 'Preventive strategies to lower the burden of Lyme borreliosis: a cost-utility analysis'. Together they form a unique fingerprint.

Cite this